Core Scientific, Inc. common stock is the subject of a proposed sale of 140,000 shares for the account of the Todd DuChene Revocable Trust, with an aggregate market value of $2,157,400.00. Morgan Stanley Smith Barney LLC is named as broker and NASDAQ as the sale venue. Todd DuChene is identified as an officer. The notice also lists prior sales by the trust under 10b5-1, including 10,000 shares on October 5, 2026.
Todd M. Duchene, Core Scientific, Inc.’s Chief Legal and Administrative Officer, sold 10,000 common shares on October 5, 2026, at a weighted average of $16.3056 per share under a Rule 10b5-1 trading plan adopted December 5, 2025. The shares were sold in multiple transactions at prices ranging from $15.90 to $16.75. Following the sale, Duchene held 1,169,668 shares directly; a grantor retained annuity trust of which he is sole trustee held 700,000 shares.
On October 1, 2026, Core Scientific, Inc. CEO Adam Taylor Sullivan had 23,508 shares withheld to satisfy tax obligations when previously granted restricted stock units vested; this was not an open-market sale. The reported price was $15.98 per share, and his direct holdings afterward were 4,412,918 shares.
Core Scientific, Inc. Chief Legal and Administrative Officer Todd M. Duchene had 8,228 shares withheld on October 1, 2026, to satisfy tax obligations upon vesting of previously granted restricted stock units; the reported price was $15.98 per share. The withholding was not an open-market sale. After the transaction, he directly held 1,179,668 shares; a grantor retained annuity trust of which he is sole trustee held 700,000 shares indirectly.
Core Scientific, Inc. Chief Legal and Administrative Officer Todd M. Duchene reported selling 10,000 shares of common stock on September 28, 2026, at a weighted average price of $16.7586 per share. The shares were sold in multiple transactions at prices ranging from $16.44 to $17.20 under a Rule 10b5-1 trading plan adopted December 5, 2025. After the sale, Duchene directly held 1,187,896 shares; 700,000 shares were held by a grantor retained annuity trust for which he is sole trustee.
Core Scientific, Inc. (CORZ) Chief Legal and Administrative Officer Todd M. Duchene sold 10,000 shares on September 21, 2026, at a weighted average price of $18.3746 per share. The shares were sold in multiple transactions at prices ranging from $17.81 to $18.64, inclusive.
The sale was made under a Rule 10b5-1 trading plan adopted December 5, 2025. Duchene reported 1,197,896 shares held directly following the sale. A separate holding entry lists 700,000 shares held by a grantor retained annuity trust of which he is the sole trustee.
Core Scientific, Inc. (CORZ) director Eric Stanton Weiss purchased 6,000 shares of Common Stock on September 15, 2026, in a purchase classified as an open market or private transaction at $16.33 per share. Following this trade, he directly holds 265,262 shares of Core Scientific common stock. No Rule 10b5-1 trading plan is reported for this transaction.
Core Scientific, Inc. (CORZ) reports that its Chief Legal and Administrative Officer, Todd M. Duchene, sold 10,000 shares of common stock on September 14, 2026 in an open-market transaction at a weighted average price of $17.14 per share, under a Rule 10b5-1 trading plan adopted on December 5, 2025.
After this sale, he continues to hold 1,207,896 shares of common stock directly and an additional 700,000 shares indirectly through a grantor retained annuity trust for which he is the sole trustee.
Core Scientific, Inc. (CORZ) reported that its Chief Legal and Administrative Officer, Todd M. Duchene, sold 10,000 shares of common stock on September 8, 2026 at a weighted average price of $18.6735 per share under a Rule 10b5-1 trading plan adopted on December 5, 2025, leaving him with 1,217,896 shares held directly. On September 9, 2026, he made a charitable donation of 95,000 Tranche 1 Warrants, each exercisable for one share of common stock at $6.81 per share until January 23, 2027, with 422,133 such warrants remaining. A separate transfer on September 10, 2026 moved 700,000 shares of common stock into a grantor retained annuity trust of which he is the sole trustee, which are now reported as held indirectly.
Core Scientific, Inc. (CORZ) reports updated electrical power status for its existing and planned data centers in Texas under ERCOT’s large-load review framework. At Denton, 297 Megawatts of existing power has been conditionally approved as “Base Load, Pathway (a)” and is classified as longstanding existing load not subject to the Batch Zero allocation process. An additional 74 Megawatts at Denton was previously incorporated in ERCOT’s 2025 Regional Transmission Plan study cases and is also outside the Batch Zero process.
At Pecos, 300 Megawatts of existing power and an additional 300 Megawatts of “Studied Load” have been conditionally approved in Batch Zero as “Base Load, Pathway (b).” All required documentation and financial collateral for Pecos have been submitted and posted, though final allocation and load ramp will follow completion of Batch Zero. At Hunt, 431 Megawatts of planned power has been conditionally approved in Batch Zero as “Base Load, Advancing Large Load, Pathway (e),” with interconnection studies completed, ERCOT stability approval received, financial collateral posted, long-lead equipment ordered, and construction commenced.